Heart valve calcifications in patients with end-stage renal disease: Analysis for risk factors

Nephrology

Volumn 11, Issue 6, 2006, Pages 494-496

  Tarrass, Faissal ^a,b   Benjelloun, Meryem ^a   Zamd, Mohamed ^a   Medkouri, Ghislaine ^a   Hachim, Khadija ^a   Benghanem, Mohamed Gharbi ^a   Ramdani, Benyounes ^a  

^a IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

^b NONE   (Morocco)

Author keywords

Calcium; End stage renal disease; Haemodialysis; Phosphorus; Risk factor; Valve calcification

Indexed keywords

ALFACALCIDOL; CALCIUM; CALCIUM CARBONATE; LIPID; PARATHYROID HORMONE; PHOSPHATE; PHOSPHORUS; VITAMIN D;

ADULT; AORTA VALVE; ARTICLE; CALCIFICATION; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; CALCIUM METABOLISM; CALCULATION; CHELATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GEOMETRY; HEART VALVE; HEART VALVE CALCIFICATION; HEART VENTRICLE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERPARATHYROIDISM; INFLAMMATION; INTESTINE; KIDNEY FAILURE; M MODE ECHOCARDIOGRAPHY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; NUTRITIONAL ASSESSMENT; PATHOGENESIS; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT DURATION; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; AORTIC VALVE STENOSIS; CALCINOSIS; CALCIUM; ECHOCARDIOGRAPHY; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MITRAL VALVE STENOSIS; PARATHYROID HORMONE; PHOSPHORUS; PREVALENCE; RENAL DIALYSIS; RISK FACTORS;

EID: 33845683791     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2006.00696.x     Document Type: Article

References (16)

1. Yee-Moon Wang A, Sin-Yee Ho S, Wang M et al. Cardiac valvular calcification as a marker of atherosclerosis and arterial calcification in end-stage renal disease. Arch. Intern. Med. 2005; 165: 327-32.
2. Boon A, Cheriex E, Lodder J, Kessels F. Cardiac valve calcification: Characteristics of patients with calcification of the mitral annulus or aortic valve. Heart 1997; 78: 472-4.
3. Raine AEG. Acquired aortic stenosis in dialysis patients. Nephron 1994; 68: 159-68.
4. Guerin AP, London GM, Marchais SJ, Metivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol. Dial. Transplant. 2000; 15: 1014-21.
5. Koren MJ, Devereux RB, Casale PN et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann. Intern. Med. 1991; 114: 345-52.
6. Devereux R, Reichek N. Echocardiographic determination of left ventricular mass in man: Anatomic validation of the method. Circulation 1997; 55: 613-18.
7. Braun J, Oldendorf M, Moshage W et al. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am. J. Kidney Dis. 1996; 27: 394-401.
8. Huting J. Mitral valve calcification as an index of left ventricular dysfunction in patients with end stage renal disease on peritoneal dialysis. Chest 1994; 105: 383-8.
9. Ribeiro S, Ramos A, Brandao A et al. Cardiac valve calcification in haemodialysis patients: Role of calcium-phosphate metabolism. Nephrol. Dial. Transplant. 1998; 13: 2037-40.
10. Block GA, Port FK. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management. Am. J. Kidney Dis. 2000; 35: 1226-37.
11. Ganesh SK, Stack AG, Levin NW et al. Association of elevated serum PO4, Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J. Am. Soc. Nephrol. 2001; 12: 2131-8.
12. Rufino M, Garcia S, Jimenez A et al. Heart valve calcification and calcium x phosphorus product in the hemodialysis patient. Analysis of optimal values for its prevention. Kidney Int. 2003; 63 (Suppl. 85): S115-18.
13. Urena P, Malergue MC, Goldfarb B et al. Evolutive aortic stenosis in hemodialysis patients: Analysis of risk factors. Néphrologie 1999; 20: 217-25.
14. Yoshida M, Takamatsu J, Yoshida S et al. Scores of coronary calcification determined by electron beam computed tomography are closely related to the extent of diabetes-specific complications. Horm. Metab. Res. 1999; 31: 558-63.
15. Torun D, Sezer S, Baltali M et al. Association of cardiac valve calcification and inflammation in patients on hemodialysis. Ren. Fail. 2005; 27: 221-6.
16. Pecoits-Filho R, Lindholm B, Stenvinkel P. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome: The heart of the matter. Nephrol. Dial. Transplant. 2002; 17 (Suppl. 11): 28-31.